Management of Pre-Menstrual Symptoms with the help of Brahmi churna and Jatamansi churna capsule

Phase 2

Not yet recruiting

• Conditions: Disorders of endocrine glands in diseases classified elsewhere. Ayurveda Condition: APANAVRUTA-VYANAVATAH,

• Registration Number: CTRI/2023/07/055516
• Lead Sponsor: Parul Institute Of Ayurveda

Brief Summary

Premenstrual syndrome is recognized as a psycho-neuro-endocrine disorder of unknown aetiology PMS encompasses a wide variety of emotional and physical symptoms that occur from several days to week before the onset of menstrual flow Various hypotheses are postulated to explain the etiopathogenesis of PMS.

Brahmi churna is very effective in psycho-neuro-endocrinal symptoms which relieves that symptoms and improves quality life of female.

Patients will be assesed on the basis of

1 PMS self rating scale

2.PMS Observer rating scale

3.PMS Vas scale

Detailed Description

Not available

Study Timeline

• Study Start: 2023-01-08
• Last Update Posted: 2024-08-22

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

• Age between 18 yrs to 40 yrs of age irrespective of socio economic status and in good medical health 2.
• Female subjects having regular menstrual cycle with cycle length of 21-35 days.
• Having a minimum PMTS score >10 and VAS score >1 4.
• Symptoms should appear at definite time in luteal phase of the cycle.
• The subject should be symptomatic for a period of last 3 or more than 3 months.
• Symptoms should not persist beyond the 5th day of menstrual cycle.
• The subjects who are ready to follow the treatment protocol and sign the informed consent.

Exclusion Criteria

• Women aged below 18 and above 40 years 2.
• Subject suffering from other acute or chronic psychiatric illness.
• Those with symptoms existing less than 3 menstrual cycles.
• Subjects suffering from organic brain diseases.
• Subjects under hormonal and psychiatric treatment.
• Subjects with premenstrual dysphoric disorder.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To subside Pre-Menstrual Symptoms	30 days

Secondary Outcome Measures

Name	Time	Method
Improvement in quality of life.	The outcomes will be measured after screening at Base Line BT after 1 month & at the end of 2 months AT Assessment of clinical parameters will also be done at the end of the 3rd month after 1 month of medicine free period

Trial Locations

Locations (1)

Parul Institute Of Ayurveda; 🇮🇳 Vadodara, GUJARAT, India

Parul Institute Of Ayurveda

🇮🇳Vadodara, GUJARAT, India

Dr Mahesh Vijay Patil

Principal investigator

7498364916

maheshp703@gmail.com